Cargando…
Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles
Fluorescent dye labeling is a common strategy to analyze the fate of administered nanoparticles in living organisms. However, to which extent the labeling processes can alter the original nanoparticle biodistribution has been so far neglected. In this work, two widely used fluorescent dye molecules,...
Autores principales: | Álamo, Patricia, Pallarès, Victor, Céspedes, María Virtudes, Falgàs, Aïda, Sanchez, Julieta M., Serna, Naroa, Sánchez-García, Laura, Voltà-Duràn, Eric, Morris, Gordon A., Sánchez-Chardi, Alejandro, Casanova, Isolda, Mangues, Ramón, Vazquez, Esther, Villaverde, Antonio, Unzueta, Ugutz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690626/ https://www.ncbi.nlm.nih.gov/pubmed/33105866 http://dx.doi.org/10.3390/pharmaceutics12111004 |
Ejemplares similares
-
Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers
por: Cano-Garrido, Olivia, et al.
Publicado: (2021) -
Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
por: Serna, Naroa, et al.
Publicado: (2022) -
Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
por: Falgàs, Aïda, et al.
Publicado: (2020) -
Artificial Inclusion Bodies for Clinical Development
por: Sánchez, Julieta M., et al.
Publicado: (2019) -
An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
por: Pallarès, Victor, et al.
Publicado: (2020)